Pfizer Inc. announced earnings results for the fourth quarter and full year ended December 31, 2017. For the quarter, the company reported revenues were $13,703 million compared to $13,627 million a year ago. Net Income was $12,274 million or $2.02 per diluted share compared to $775 million or $0.13 per diluted share a year ago. Adjusted Income was $3,772 million or $0.62 per diluted share compared to $2,894 million or $0.47 per diluted share a year ago.


For the full year, the company reported revenues were $52,546 million compared to $52,824 million a year ago. Net Income was $21,308 million or $3.52 per diluted share compared to $7,215 million or $1.17 per diluted share a year ago. Adjusted Income was $16,085 million or $2.65 per diluted share compared to $14,761 million or $2.40 per diluted share a year ago.

For the year 2018, the company now expects to report revenues in the range of $53.5 to $55.5 billion and adjusted Diluted earnings per share in the range of $2.90 to $3.00. Effective tax rate on adjusted income is expected to be approximately 17%. Adjusted SI&A Expenses in the range of $14.0 to $15.0 billion. Adjusted R&D Expenses in the range of $7.4 to $7.9 billion.